September 2018 Issue

GO TO FULL ISSUE

MED UPDATES

Eucrisa
crisaborole
A topical PDE-4 inhibitor for mild/moderate atopic dermatitis

Dupixent
dupilumab
An IL-4 and IL-13 blocker for moderate to severe atopic dermatitis

Siliq
brodalumab
An IL-17RA blocker for moderate to severe plaque psoriasis

MORE MED UPDATES